Medicines

Medical Product Alert N°5/2020 - 7 May 2020 1

Medical Product Alert N°5/2020 – 7 May 2020

Falsified and contaminated Defibrotide identified in WHO regions of Western Pacific, Europe and Eastern Mediterranean This alert relates to falsified DEFIBROTIDE 200MG VIALS OF 2.5ML (80MG/ML) CONCENTRATE FOR SOLUTION FOR INFUSION identified in Australia, Latvia and Saudi Arabia. This product is sold under the brand name Defitelio. On 13 March 2020, the WHO Global Surveillance and […]

Medical Product Alert N°5/2020 – 7 May 2020 Read More »

Indonesia firmly committed to eliminating lymphatic filariasis as a public health problem 8

Indonesia firmly committed to eliminating lymphatic filariasis as a public health problem

Indonesia recently completed the last of its annual large-scale treatment for lymphatic filariasis (also known as elephantiasis or Penyakit Kaki Gajah) in Malaka District located in its southernmost province, East Nusa Tenggara. Unprecedented progress by the National Lymphatic Filariasis Elimination Programme has strongly placed the country on the path to achieving the elimination of lymphatic filariasis

Indonesia firmly committed to eliminating lymphatic filariasis as a public health problem Read More »

New estimates highlight need to step up the response to hepatitis D

Lyon, France, 29 April 2020 – In a study published in the Journal of Hepatology, 1 Professor Anna Maria Geretti and Dr Alexander Stockdale from the University of Liverpool (United Kingdom), in collaboration with researchers from the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC), estimate that worldwide, hepatitis D

New estimates highlight need to step up the response to hepatitis D Read More »

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19 9

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19

Heads of state and global health leaders today made an unprecedented commitment to work together to accelerate the development and production of new vaccines, tests and treatments for COVID-19 and assure equitable access worldwide. The COVID-19 pandemic has already affected more than 2.4 million people, killing over 160,000. It is taking a huge toll on

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19 Read More »

WHO urges countries to move quickly to save lives from malaria in sub-Saharan Africa 10

WHO urges countries to move quickly to save lives from malaria in sub-Saharan Africa

Severe disruptions to insecticide-treated net campaigns and in access to antimalarial medicines could lead to a doubling in the number of malaria deaths in sub-Saharan Africa this year compared to 2018, according to a new modelling analysis released by WHO and partners ahead of World Malaria Day (25 April). WHO urges countries to move fast

WHO urges countries to move quickly to save lives from malaria in sub-Saharan Africa Read More »

WHO lists two COVID-19 tests for emergency use

WHO has listed the first two diagnostic tests for emergency use during the Covid-19 pandemic. The move should help increase access to quality-assured, accurate tests for the disease.  It also means that the tests can now be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. Both in vitro diagnostics, the

WHO lists two COVID-19 tests for emergency use Read More »

virtual-press-conference-on-covid-19-06-april-2020

Virtual Press Conference on COVID-19- 06 April 2020

  Originally broadcast live on 06 April 2020, the daily press briefing on coronavirus COVID-19, direct from WHO Headquarters, Geneva Switzerland with Dr Tedros WHO Director-General, Dr Micheal Ryan, Executive Director of the Health Emergencies Programme, and Dr Maria Van Kerkhove, Technical lead, WHO Health Emergencies Programme with special guests Lady Gaga and Hugh Evans,

Virtual Press Conference on COVID-19- 06 April 2020 Read More »

making-available-free-paediatric-medicine-can-accelerate-elimination-of-congenital-chagas-disease

Making available free paediatric medicine can accelerate elimination of congenital Chagas disease

The donation of an essential antiparasitic medicine can potentially accelerate the elimination of Chagas disease infection in children. A pediatric presentation of benznidazole with accurate dosage and will soon be made available freely to address a long-standing gap in the treatment of congenital infections of Chagas disease.   The donation, by the Mundo Sano Foundation1 and

Making available free paediatric medicine can accelerate elimination of congenital Chagas disease Read More »

Shopping Cart